(Q41345430)

29 September 2017

title

Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? (English)

1 reference

29 September 2017

0 references

J E Grundy

1

1 reference

29 September 2017

J D Shanley

series ordinal

2

1 reference

29 September 2017

P D Griffiths

series ordinal

3

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 October 1987

1 reference

29 September 2017

1 reference

29 September 2017

volume

2

1 reference

29 September 2017

issue

8566

1 reference

29 September 2017

page(s)

996-999

1 reference

Risk factors for cytomegalovirus infection after human marrow transplantation

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Nonbacterial nonfungal pneumonia following marrow transplantation in 100 identical twins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

The Transplanted Kidney as a Source of Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Reinfection of a seropositive allograft recipient by cytomegalovirus from donor kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Cytomegalovirus Infection in Patients with Renal Transplants: Potentiation by Antithymocyte Globulin and an Incompatible Graft

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Specific hyperimmune globulin for cytomegalovirus pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Cytomegalovirus in urine specimens has host beta 2 microglobulin bound to the viral envelope: a mechanism of evading the host immune response?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Cytomegalovirus strain AD169 binds beta 2 microglobulin in vitro after release from cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Detection of cytomegalovirus by ELISA in urine samples is inhibited by beta 2 microglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

The Pathogenesis of Pneumonitis Due to Murine Cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements forin vitro generation and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Inhibition of human T lymphocyte function with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

Beta 2 microglobulin enhances the infectivity of cytomegalovirus and when bound to the virus enables class I HLA molecules to be used as a virus receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992560-8

7 January 2021

10.1016/S0140-6736(87)92560-8

Identifiers

DOI

1 reference

29 September 2017

1 reference